Invitae Corporation Revenue per Employee (NVTA), current and historic results, rankings and more, quarterly fundamentals - CSIMarket
CSIMarket Company Name, Ticker, Industry, else..
 


• Sales per Employee
• Income per Employee
• Inventory Turnover
• Asset Turnover
• Receivables Turnover
Invitae Corporation  (NYSE: NVTA)
    Sector • Healthcare    Industry • Medical Laboratories
   Industry • Medical Laboratories
   Sector • Healthcare
 

Invitae's Revenue per Employee

Quarterly Results, Trends, Rankings, Statistics, Cumulative Sales


Invitae's Revenue per employee fell on a trailing twelve month basis to $ 401,319, but the productivity of Invitae's employees remained above the company average.
Within the Healthcare sector Employees of 149 other companies have achieved higher revenue per employee. While Invitae's total ranking has deteriorated compared to the previous quarter from 1317 to 1390. Invitae has 1,200 employees.


What is Sales per Employee Ratio?






Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

NVTA Revenue per Employee (Sep 30 2023)
III. Quarter		 (Jun 30 2023)
II. Quarter		 (Mar 31 2023)
I. Quarter		 (Dec 31 2022)
IV. Quarter		 (Sep 30 2022)
III. Quarter
Y / Y Revenue Change -9.21 % -11.78 % -5.12 % -2.91 % 16.73 %
Sales per Employee (TTM) $ 401,319 411,565 424,973 430,253 433,308
NVTA's Total Ranking # 1390 # 1317 # 1468 # 1576 # 0
Seq. Revenue Change 0.59 % 2.71 % -4.16 % -8.3 % -2.26 %

NVTA Company Profile >> Back to NVTA Efficiency Comparisons >> Compare NVTA Sales per Employee to its Competitors

Revenue per Employee Company Ranking
Within: No.
Medical Laboratories Industry # 9
Healthcare Sector # 150
Overall Market # 1390

Revenue per Employee Statistics
High Average Low
$ 346,647 $ 179,563 $ 16,699
(Sep 30 2022)   (Dec 31 2016)



Financial Statements
Invitae's Revenue MRQ $ 121 Millions Visit NVTA's Income Statement
Invitae's Revenues TTM $ 482 Millions Visit NVTA's aggregate revenue growth
What are NVTA's Sales? Visit NVTA's Sales by Segment




Other Ratios
Invitae's Income per Employee
Employees in Medical Laboratories
Medical Laboratories Industry Revenue per Employee Trends and Statistics
Healthcare Sector Revenue per Employee Statistics
Revenue per Employee Trends for overall market
NVTA's Revenue per Employee versus Medical Laboratories Industry, Healthcare Sector and total Market
Highest Ranking Revenue per Employee
Lowest Ranking Revenue per Employee
Revenue per Employee for NVTA's Competitors
Revenue per Employee for NVTA's Suppliers
Revenue per Employee for NVTA's Customers

You may also want to know
NVTA's Sales Growth Rates NVTA's Pe Price to earnings ratio NVTA's Receivables Turnover Ratio NVTA's Stock Quote
NVTA's Net Income Growth Rates NVTA's Ps Price to Sales ratio NVTA's Sales per Employee NVTA's Asset Turnover Ratio
NVTA's Net Margin NVTA's Pb Price to Book ratio NVTA's Financial Strength Ratios NVTA's Dividend Payout Ratio
Date modified: 2026-09-08T15:11:06+00:00




Companies with similar Revenue per Employee for 12 months ending Sep 30 2023, within Healthcare Sector Revenue per Employee Revenue 12 months ending Sep 30 2023Number of Employees Sep 30 2023
Alnylam Pharmaceuticals Inc   689,443.60 $ 1,723.609  Million 2,500 
Cardiff Lexington Corporation  685,973.56 $ 12.348  Million 18 
Arvinas Inc   679,674.80 $ 167.200  Million 246 
Kiniksa Pharmaceuticals International Plc  679,639.34 $ 248.748  Million 366 
Ati Physical Therapy Inc   678,488.00 $ 678.488  Million 1,000 
Denali Therapeutics Inc   677,562.62 $ 340.814  Million 503 
Johnson and Johnson  677,080.97 $ 95,333.000  Million 140,800 
Enanta Pharmaceuticals Inc  660,033.33 $ 79.204  Million 120 
Fate Therapeutics Inc   659,708.07 $ 106.213  Million 161 
Werewolf Therapeutics Inc   659,615.38 $ 25.725  Million 39 
Milestone Scientific Inc   652,525.20 $ 9.788  Million 15 
Ginkgo Bioworks Holdings Inc   649,453.61 $ 314.985  Million 485 
Skinhealth Systems Inc   648,831.97 $ 397.734  Million 613 
Eli Lilly And Company  641,450.00 $ 32,072.500  Million 50,000 
Karyopharm Therapeutics Inc   639,763.16 $ 145.866  Million 228 
Corcept Therapeutics Inc  616,473.97 $ 450.026  Million 730 
Organon and Co   615,000.00 $ 6,150.000  Million 10,000 
Elite Pharmaceuticals Inc   611,668.03 $ 39.758  Million 65 
Theravance Biopharma inc   605,644.44 $ 54.508  Million 90 
Embecta Corp   605,351.35 $ 1,119.900  Million 1,850 
Healthlynked Corp  594,628.50 $ 5.946  Million 10 
Dyadic International Inc   591,199.40 $ 2.956  Million 5 
Zoetis Inc   577,310.34 $ 8,371.000  Million 14,500 
Perrigo Company Plc  574,345.68 $ 4,652.200  Million 8,100 
Iridex Corp  571,150.54 $ 53.117  Million 93 
Sanara Medtech Inc   571,087.38 $ 61.677  Million 108 
Hologic Inc  570,070.72 $ 4,030.400  Million 7,070 
Accuray Incorporated  561,934.49 $ 454.605  Million 809 
Xencor Inc  558,688.46 $ 145.259  Million 260 
Palatin Technologies Inc   553,636.45 $ 6.090  Million 11 




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.